Filing Details
- Accession Number:
- 0001610717-23-000278
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-09-12 17:24:25
- Reporting Period:
- 2023-09-08
- Accepted Time:
- 2023-09-12 17:24:25
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1437402 | Ardelyx Inc. | ARDX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1611311 | P. David Rosenbaum | C/O Ardelyx, Inc. 34175 Ardenwood Blvd, Suite 100 Fremont CA 94555 | Chief Development Officer | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2023-09-08 | 2,897 | $4.55 | 367,022 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 114,225 | Indirect | By Wife |
Common Stock | 77,592 | Indirect | Family Trust |
Footnotes
- Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on June 9, 2023.
- Reflects the adjusted total which includes the purchase of 3,000 shares under the Ardelyx Employee Stock Purchase Plan on August 31, 2023.
- The shares are directly held by the Reporting Person's wife.
- The shares are directly held by David Paul Rosenbaum and Susan Edelstein Rosenbaum, Trustees of the David Paul Rosenbaum Family Trust.